Display Settings:

Format

Send to:

Choose Destination
    Lupus. 2005;14 Suppl 1:s58-63.

    Mycophenolate mofetil and skin diseases.

    Source

    Department of Dermatology, University of Heidelberg, Heidelberg, Germany. Martin-Hartmann@med.uni-heidelberg.de

    Abstract

    Mycophenolate mofetil (MMF) is an immunosuppressive drug the efficiency of which has been established in renal transplantation. Recent studies suggest that it may also be effective in the treatment of variant skin diseases especially if the skin lesions are triggered by lymphocytes. Studies have shown efficacy in autoimmune bullous dermatoses, atopic dermatitis and psoriasis. However, there are no placebo-controlled trials that support the use of MMF as first line therapy in these skin diseases.

    PMID:
    15803935
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk